|
Volumn 109, Issue 20, 2012, Pages
|
Normalization of the tumor vasculature through oncogenic inhibition: An emerging paradigm in tumor biology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
RAS PROTEIN;
TRASTUZUMAB;
ANGIOGENESIS;
ANTIANGIOGENIC THERAPY;
BREAST CANCER;
CELL PROLIFERATION;
CELL SURVIVAL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
GENE CONTROL;
GENE MUTATION;
HUMAN;
LETTER;
OXYGEN CONSUMPTION;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTO ONCOGENE;
SIGNAL TRANSDUCTION;
TISSUE OXYGENATION;
TISSUE PERFUSION;
TREATMENT RESPONSE;
TUMOR GROWTH;
TUMOR MICROENVIRONMENT;
TUMOR VASCULARIZATION;
ANIMALS;
HUMANS;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS B-RAF;
|
EID: 84861215641
PISSN: 00278424
EISSN: 10916490
Source Type: Journal
DOI: 10.1073/pnas.1203794109 Document Type: Letter |
Times cited : (32)
|
References (5)
|